comparison of ceftriaxone plus weekly azithromycin or daily ofloxacin for outpatient treatment of pelvic inflammatory disease: a randomized clinical trial
نویسندگان
چکیده
objective: to compare the efficacy of ceftriaxone plus ofloxacin or azithromycin for cases of pelvic inflammatory disease (pid). materials and methods: this clinical terial was performed on 180 women with pid from march 2005 to march 2007 in parastarane-shahed hospital. patients with pid were randomly divided to receive injection of ceftriaxone 250 mg plus ofloxacin 200 mg per day or azithromycin 1 g per week for two weeks (90 cases in each group). the degree of pain was assessed on days 7, 14, 30 and clinical cure was assessed on days 14 and 30. statistical analysis was done based on fisher exact test, mann-whitny and student t-test. results: from 180 patients eligible for the study, 138 cases were enrolled for protocol analysis. significant differences were observed regarding the degree of pain between two groups. clinical cure was 90% (70 of 78) for azithromycin and 83.3% (50 of 60) for ofloxacin. conclusion: combination of ceftriaxone plus weekly azithromycin for two weeks is not only equivalent to ceftriaxone plus daily ofloxacin for two weeks but also seems to be better for the treatment of mild pid.
منابع مشابه
Doxycycline or Ofloxacin for Outpatient Chlamydial Pelvic Inflammatory Disease? A Cost-Benefit and Cost-Effectiveness Analysis
OBJECTIVE The current Centers for Disease Control and Prevention (CDC) guidelines include 2 drugs, doxycycline and ofloxacin, for treatment of the chlamydial component of outpatient pelvic inflammatory disease (PID). Although ofloxacin costs about $90 more than doxycycline, doxycycline is frequently associated with side effects and patient compliance with this drug is probably poor. Because cli...
متن کاملcomparison of zoe and vitapex for canal treatment of necrotic primary teeth
چکیده ندارد.
15 صفحه اولComparison of Ofloxacin & Ornidazole with Probiotic versus Doxycycline & Metronidazole for the Outpatient Treatment of Pelvic Inflammatory Disease
Introduction Pelvic inflammatory disease (PID) is a polymicrobial infection of upper genital tract (usually fallopian tubes).It is a serious infectious disease of sexually active women with sequelae such as infertility and ectopic pregnancy (1, 2). It is most commonly caused by Neisseria gonorrhoea, Chlamydia trachomatis and other aerobic and anaerobic pathogens (3, 4). Most patients of PID are...
متن کاملComparison of Spironolactone plus Cyproterone Acetate plus Cyproterone Compound with Spironolactone plus Cyproterone Compound in Hirsutism: A randomized clinical trial
Background: Monotherapy is not usually effective in the treatment of hirsutism. Objective: Comparison of 2 therapeutic regimens in the treatment of hirsutism. Patients and methods: In this open parallel controlled clinical trial, 101 Patients suffering from hirsutism were randomly divided into two equal groups. 50 patients were treated with spironolactone (50 mg/day) plus cyproterone comp...
متن کاملOfloxacin plus Rifampicin versus Doxycycline plus Rifampicin in the treatment of brucellosis: a randomized clinical trial [ISRCTN11871179]
BACKGROUND The combination therapies recommended by the World Health Organization for treatment of brucellosis are doxycycline plus rifampicin or doxycycline plus streptomycin. Although highly successful results have been obtained with these two regimens, relapse rates as high as 14.4%. The most effective and the least toxic chemotherapy for human brucellosis is still undetermined. The aim of t...
متن کاملComparison of the efficacy of oral fenugreek seed extract and azithromycin in the treatment of acne vulgaris: a randomized, triple-blind controlled pilot clinical trial
Background: Acne vulgaris is a multi-factorial disease affecting many aspects of life. This study was conducted to compare the efficacy of fenugreek seed extract and oral azithromycin in the treatment of acne vulgaris. Methods: A total of 20 patients with acne vulgaris aged between 12 and 30 years old were entered into this 60-day, randomized, placebo-controlled, triple-blind study. The patient...
متن کاملمنابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
journal of family and reproductive healthجلد ۲، شماره ۲، صفحات ۸۷-۹۴
کلمات کلیدی
میزبانی شده توسط پلتفرم ابری doprax.com
copyright © 2015-2023